BMC's ₹4.99 Crore AI Project Sent Back Over Tender Issues

The Brihanmumbai Municipal Corporation (BMC) administration's proposal to spend ₹4.99 crore on an artificial intelligence (AI)-based system for diagnosing neurological diseases at KEM Hospital was sent back on Wednesday.

The proposal was to introduce the technology on a pilot basis for 150 patients suffering from epilepsy and brain tumours over 12 months. However, members of the Standing Committee raised questions over the lack of a proper tendering process and the selection of a Bengaluru-based IT firm, BrainSightAI Technology Pvt Ltd.

Congress corporator from Kurla, Ashraf Azmi, questioned why a Bengaluru-based IT company was being selected for the project and said other technology firms should also be given a level playing field to participate through a transparent tendering process. Azmi also questioned what would happen after the one-year pilot period ends, particularly if patients continue to require the technology and are eventually asked to pay for the service.

The proposed technology is limited to diagnosis and analysis and does not provide treatment. Members of the Standing Committee sought clarity on the project, asking if the civic body was only focusing on diagnosis or also looking at treatment. They also sought greater clarity on the long-term plan, selection process, and financial implications of the project.

According to the proposal, BrainSightAI Technology Pvt Ltd was proposed to be paid ₹4.99 crore for implementing the AI- and neuroscience-based project at KEM Hospital. The system was proposed to be used on 150 epilepsy and brain tumour patients for 12 months to assist in diagnosis and analysis and monitor changes in patients’ condition after surgery.

Members raised concerns over the manner in which the company was selected and sought a transparent process that would allow other eligible IT and technology companies to compete. Following the objections, the BMC administration withdrew the proposal from the meeting for reconsideration instead of putting it to a vote.

The BMC's proposal is part of its efforts to leverage technology to improve healthcare services in the city. The use of AI in healthcare has the potential to revolutionize the way diseases are diagnosed and treated. However, the civic body must ensure that any such project is implemented in a transparent and fair manner.

The withdrawal of the proposal is a setback for the BMC's plans to introduce AI-based healthcare services at KEM Hospital. The civic body will now have to reconsider the proposal and address the concerns raised by the members of the Standing Committee.

In the long run, the use of AI in healthcare can have a significant impact on the city's healthcare services. It can help improve diagnosis accuracy, reduce treatment costs, and enhance patient care. However, it is essential that such projects are implemented in a transparent and fair manner, with proper consideration for the long-term implications and financial viability.

The BMC's decision to withdraw the proposal is a positive step towards ensuring that the project is implemented in a fair and transparent manner. The civic body must now work towards addressing the concerns raised by the members of the Standing Committee and ensure that the project is implemented in a way that benefits the citizens of Mumbai.

The proposal's withdrawal also highlights the need for greater transparency and accountability in the civic body's decision-making process. The BMC must ensure that all projects, including those related to healthcare, are implemented in a fair and transparent manner, with proper consideration for the long-term implications and financial viability.

In conclusion, the BMC's proposal to spend ₹4.99 crore on an AI-based system for diagnosing neurological diseases at KEM Hospital has been sent back due to concerns over the tendering process and selection of the IT firm. The civic body must now work towards addressing these concerns and ensuring that the project is implemented in a fair and transparent manner.